301 related articles for article (PubMed ID: 23802413)
1. Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha.
He Z; Yu Y; Zhang Y; Yan Y; Zheng Y; He J; Xie Y; He G; Wei Y; Song X
J Biomed Nanotechnol; 2013 May; 9(5):833-44. PubMed ID: 23802413
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and properties of folate receptor-targeted cationic liposomes].
Yan Y; Qi XR
Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
[TBL] [Abstract][Full Text] [Related]
3. Novel serum-tolerant lipoplexes target the folate receptor efficiently.
Gorle S; Ariatti M; Singh M
Eur J Pharm Sci; 2014 Aug; 59():83-93. PubMed ID: 24769039
[TBL] [Abstract][Full Text] [Related]
4. PEGylated galactosylated cationic liposomes for hepatocytic gene delivery.
Naicker K; Ariatti M; Singh M
Colloids Surf B Biointerfaces; 2014 Oct; 122():482-490. PubMed ID: 25096720
[TBL] [Abstract][Full Text] [Related]
5. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery.
He ZY; Zheng X; Wu XH; Song XR; He G; Wu WF; Yu S; Mao SJ; Wei YQ
Int J Pharm; 2010 Sep; 397(1-2):147-54. PubMed ID: 20667672
[TBL] [Abstract][Full Text] [Related]
6. Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor.
Tang M; Sakasai S; Onishi H; Kawano K; Hattori Y
J Drug Target; 2023 Jan; 31(1):74-88. PubMed ID: 35864749
[TBL] [Abstract][Full Text] [Related]
7. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
8. Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells.
Hattori Y; Shimizu S; Ozaki KI; Onishi H
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30991703
[TBL] [Abstract][Full Text] [Related]
9. Preparation, therapeutic efficacy and intratumoral localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS.
Xiong S; Yu B; Wu J; Li H; Lee RJ
Biomed Pharmacother; 2011 Feb; 65(1):2-8. PubMed ID: 21177069
[TBL] [Abstract][Full Text] [Related]
10. α, ω-Cholesterol-functionalized low molecular weight polyethylene glycol as a novel modifier of cationic liposomes for gene delivery.
Ma CC; He ZY; Xia S; Ren K; Hui LW; Qin HX; Tang MH; Zeng J; Song XR
Int J Mol Sci; 2014 Nov; 15(11):20339-54. PubMed ID: 25383677
[TBL] [Abstract][Full Text] [Related]
11. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
12. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
[TBL] [Abstract][Full Text] [Related]
13. Divalent folate modification on PEG: an effective strategy for improving the cellular uptake and targetability of PEGylated polyamidoamine-polyethylenimine copolymer.
Cao D; Tian S; Huang H; Chen J; Pan S
Mol Pharm; 2015 Jan; 12(1):240-52. PubMed ID: 25514347
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
[TBL] [Abstract][Full Text] [Related]
15. Receptor-targeted gene delivery via folate-conjugated polyethylenimine.
Guo W; Lee RL
AAPS PharmSci; 1999; 1(4):E19. PubMed ID: 11741215
[TBL] [Abstract][Full Text] [Related]
16. A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.
Huang Y; Yang T; Zhang W; Lu Y; Ye P; Yang G; Li B; Qi S; Liu Y; He X; Lee RJ; Xu C; Xiang G
Int J Nanomedicine; 2014; 9():4581-95. PubMed ID: 25302024
[TBL] [Abstract][Full Text] [Related]
17. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
18. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery.
Gosselin MA; Guo W; Lee RJ
Bioconjug Chem; 2002; 13(5):1044-53. PubMed ID: 12236787
[TBL] [Abstract][Full Text] [Related]
20. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
